APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

3D Printing Pharmaceuticals

3D Printing Pharmaceuticals refers to manufacturing, research or inspection activity in the named process and application category.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Delivered scope, source model, material, process, evidence and acceptance criteria define the work; materials, machines and contracted services must be separated.

What turns activity into demand

Procurement depends on the agreed deliverable, integration, rights and continuing support. Separate initial projects or software access from repeat service work when interpreting the selected market study.

The commercial boundary

Define delivered work, software rights, hardware and continuing services separately. The selected edition describes its research coverage, rather than establishing supplier capabilities.

Which supplied scope and interfaces define 3D Printing Pharmaceuticals?

Delivered scope, source model, material, process, evidence and acceptance criteria define the work; materials, machines and contracted services must be separated.

Selected research

Market Structure

Global 3D Printing Pharmaceuticals Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 173959010321 December 2025195 pages

Choose your research edition.

Industry Research3D Printing Pharmaceuticals Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal 3D Printing Pharmaceuticals Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal 3D Printing Pharmaceuticals Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal 3D Printing Pharmaceuticals Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal 3D Printing Pharmaceuticals Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global 3D Printing Pharmaceuticals market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for 3D Printing Pharmaceuticals is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for 3D Printing Pharmaceuticals is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for 3D Printing Pharmaceuticals is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for 3D Printing Pharmaceuticals is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of 3D Printing Pharmaceuticals include Merck KGaA, Merck, AstraZeneca, Triastek,Inc., TNO, Therics, Multiply Labs, FabRx and DiHeSys, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global 3D Printing Pharmaceuticals market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of 3D Printing Pharmaceuticals and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents 3D Printing Pharmaceuticals sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the 3D Printing Pharmaceuticals market size, projected growth trends, production technologies, key applications, and end-use industries.

3D Printing Pharmaceuticals Segment by Company

Merck KGaA

Merck

AstraZeneca

Triastek,Inc.

TNO

Therics

Multiply Labs

FabRx

DiHeSys

Aprecia

3D Printing Pharmaceuticals Segment by Type

DPE

SLS

MDD

FDM

MED

DOD

SLA

PB

SSE

3D Printing Pharmaceuticals Segment by Application

Personalized Pharmacy

Nutrients

3D Printing Pharmaceuticals Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global 3D Printing Pharmaceuticals market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of 3D Printing Pharmaceuticals and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of 3D Printing Pharmaceuticals.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the 3D Printing Pharmaceuticals market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of 3D Printing Pharmaceuticals manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of 3D Printing Pharmaceuticals in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of 3D Printing Pharmaceuticals in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. 3D Printing Pharmaceuticals Industry Trends Table 2. 3D Printing Pharmaceuticals Industry Drivers Table 3. 3D Printing Pharmaceuticals Industry Opportunities and Challenges Table 4. 3D Printing Pharmaceuticals Industry Restraints Table 5. Global 3D Printing Pharmaceuticals Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global 3D Printing Pharmaceuticals Revenue Market Share by Manufacturers (2021-2026) Table 7. Global 3D Printing Pharmaceuticals Sales by Manufacturers (k units) & (2021-2026) Table 8. Global 3D Printing Pharmaceuticals Sales Market Share by Manufacturers Table 9. Global 3D Printing Pharmaceuticals Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global 3D Printing Pharmaceuticals Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global 3D Printing Pharmaceuticals Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global 3D Printing Pharmaceuticals Manufacturers, Product Type & Application Table 13. Global 3D Printing Pharmaceuticals Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global 3D Printing Pharmaceuticals by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of DPE Table 17. Major Manufacturers of SLS Table 18. Major Manufacturers of MDD Table 19. Major Manufacturers of FDM Table 20. Major Manufacturers of MED Table 21. Major Manufacturers of DOD Table 22. Major Manufacturers of SLA Table 23. Major Manufacturers of PB Table 24. Major Manufacturers of SSE Table 25. Global 3D Printing Pharmaceuticals Sales by Type 2021 VS 2025 VS 2032 (k units) Table 26. Global 3D Printing Pharmaceuticals Sales by Type (2021-2026) & (k units) Table 27. Global 3D Printing Pharmaceuticals Sales by Type (2027-2032) & (k units) Table 28. Global 3D Printing Pharmaceuticals Sales Market Share by Type (2021-2026) Table 29. Global 3D Printing Pharmaceuticals Sales Market Share by Type (2027-2032) Table 30. Global 3D Printing Pharmaceuticals Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 31. Global 3D Printing Pharmaceuticals Revenue by Type (2021-2026) & (k units) Table 32. Global 3D Printing Pharmaceuticals Revenue by Type (2027-2032) & (k units) Table 33. Global 3D Printing Pharmaceuticals Revenue Market Share by Type (2021-2026) Table 34. Global 3D Printing Pharmaceuticals Revenue Market Share by Type (2027-2032) Table 35. Major Manufacturers of Personalized Pharmacy Table 36. Major Manufacturers of Nutrients Table 37. Global 3D Printing Pharmaceuticals Sales by Application 2021 VS 2025 VS 2032 (k units) Table 38. Global 3D Printing Pharmaceuticals Sales by Application (2021-2026) & (k units) Table 39. Global 3D Printing Pharmaceuticals Sales by Application (2027-2032) & (k units) Table 40. Global 3D Printing Pharmaceuticals Sales Market Share by Application (2021-2026) Table 41. Global 3D Printing Pharmaceuticals Sales Market Share by Application (2027-2032) Table 42. Global 3D Printing Pharmaceuticals Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 43. Global 3D Printing Pharmaceuticals Revenue by Application (2021-2026) & (k units) Table 44. Global 3D Printing Pharmaceuticals Revenue by Application (2027-2032) & (k units) Table 45. Global 3D Printing Pharmaceuticals Revenue Market Share by Application (2021-2026) Table 46. Global 3D Printing Pharmaceuticals Revenue Market Share by Application (2027-2032) Table 47. Global 3D Printing Pharmaceuticals Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 48. Global 3D Printing Pharmaceuticals Sales by Region (2021-2026) & (k units) Table 49. Global 3D Printing Pharmaceuticals Sales Market Share by Region (2021-2026) Table 50. Global 3D Printing Pharmaceuticals Sales Forecasted by Region (2027-2032) & (k units) Table 51. Global 3D Printing Pharmaceuticals Sales Forecasted Market Share by Region (2027-2032) Table 52. North America 3D Printing Pharmaceuticals Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 53. North America 3D Printing Pharmaceuticals Sales by Country (2021-2026) & (k units) Table 54. North America 3D Printing Pharmaceuticals Sales by Country (2027-2032) & (k units) Table 55. Europe 3D Printing Pharmaceuticals Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 56. Europe 3D Printing Pharmaceuticals Sales by Country (2021-2026) & (k units) Table 57. Europe 3D Printing Pharmaceuticals Sales by Country (2027-2032) & (k units) Table 58. Asia Pacific 3D Printing Pharmaceuticals Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 59. Asia Pacific 3D Printing Pharmaceuticals Sales by Country (2021-2026) & (k units) Table 60. Asia Pacific 3D Printing Pharmaceuticals Sales by Country (2027-2032) & (k units) Table 61. South America, Middle East and Africa 3D Printing Pharmaceuticals Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 62. South America, Middle East and Africa 3D Printing Pharmaceuticals Sales by Country (2021-2026) & (k units) Table 63. South America, Middle East and Africa 3D Printing Pharmaceuticals Sales by Country (2027-2032) & (k units) Table 64. Global 3D Printing Pharmaceuticals Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 65. Global 3D Printing Pharmaceuticals Revenue by Region (2021-2026) & (US$ Million) Table 66. Global 3D Printing Pharmaceuticals Revenue by Region (2027-2032) & (US$ Million) Table 67. Global 3D Printing Pharmaceuticals Revenue Market Share by Region (2021-2026) Table 68. Global 3D Printing Pharmaceuticals Revenue Market Share by Region (2027-2032) Table 69. Merck KGaA Company Information Table 70. Merck KGaA Business Overview Table 71. Merck KGaA 3D Printing Pharmaceuticals Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Merck KGaA 3D Printing Pharmaceuticals Product Portfolio Table 73. Merck KGaA Recent Development Table 74. Merck Company Information Table 75. Merck Business Overview Table 76. Merck 3D Printing Pharmaceuticals Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Merck 3D Printing Pharmaceuticals Product Portfolio Table 78. Merck Recent Development Table 79. AstraZeneca Company Information Table 80. AstraZeneca Business Overview Table 81. AstraZeneca 3D Printing Pharmaceuticals Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. AstraZeneca 3D Printing Pharmaceuticals Product Portfolio Table 83. AstraZeneca Recent Development Table 84. Triastek,Inc. Company Information Table 85. Triastek,Inc. Business Overview Table 86. Triastek,Inc. 3D Printing Pharmaceuticals Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Triastek,Inc. 3D Printing Pharmaceuticals Product Portfolio Table 88. Triastek,Inc. Recent Development Table 89. TNO Company Information Table 90. TNO Business Overview Table 91. TNO 3D Printing Pharmaceuticals Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. TNO 3D Printing Pharmaceuticals Product Portfolio Table 93. TNO Recent Development Table 94. Therics Company Information Table 95. Therics Business Overview Table 96. Therics 3D Printing Pharmaceuticals Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Therics 3D Printing Pharmaceuticals Product Portfolio Table 98. Therics Recent Development Table 99. Multiply Labs Company Information Table 100. Multiply Labs Business Overview Table 101. Multiply Labs 3D Printing Pharmaceuticals Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Multiply Labs 3D Printing Pharmaceuticals Product Portfolio Table 103. Multiply Labs Recent Development Table 104. FabRx Company Information Table 105. FabRx Business Overview Table 106. FabRx 3D Printing Pharmaceuticals Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. FabRx 3D Printing Pharmaceuticals Product Portfolio Table 108. FabRx Recent Development Table 109. DiHeSys Company Information Table 110. DiHeSys Business Overview Table 111. DiHeSys 3D Printing Pharmaceuticals Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. DiHeSys 3D Printing Pharmaceuticals Product Portfolio Table 113. DiHeSys Recent Development Table 114. Aprecia Company Information Table 115. Aprecia Business Overview Table 116. Aprecia 3D Printing Pharmaceuticals Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Aprecia 3D Printing Pharmaceuticals Product Portfolio Table 118. Aprecia Recent Development Table 119. Key Raw Materials Table 120. Raw Materials Key Suppliers Table 121. 3D Printing Pharmaceuticals Distributors List Table 122. 3D Printing Pharmaceuticals Customers List Table 123. Research Programs/Design for This Report Table 124. Authors List of This Report Table 125. Secondary Sources Table 126. Primary Sources List of Figures Figure 1. 3D Printing Pharmaceuticals Product Image Figure 2. Global 3D Printing Pharmaceuticals Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global 3D Printing Pharmaceuticals Market Size (2021-2032) & (US$ Million) Figure 4. Global 3D Printing Pharmaceuticals Sales (2021-2032) & (k units) Figure 5. Global 3D Printing Pharmaceuticals Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 3D Printing Pharmaceuticals Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. DPE Image Figure 9. SLS Image Figure 10. MDD Image Figure 11. FDM Image Figure 12. MED Image Figure 13. DOD Image Figure 14. SLA Image Figure 15. PB Image Figure 16. SSE Image Figure 17. Global 3D Printing Pharmaceuticals Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 18. Global 3D Printing Pharmaceuticals Sales Market Share 2021 VS 2025 VS 2032 Figure 19. Global 3D Printing Pharmaceuticals Sales Market Share by Type (2021-2032) Figure 20. Global 3D Printing Pharmaceuticals Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 21. Global 3D Printing Pharmaceuticals Revenue Market Share 2021 VS 2025 VS 2032 Figure 22. Global 3D Printing Pharmaceuticals Revenue Market Share by Type (2021-2032) Figure 23. Personalized Pharmacy Image Figure 24. Nutrients Image Figure 25. Global 3D Printing Pharmaceuticals Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 26. Global 3D Printing Pharmaceuticals Sales Market Share 2021 VS 2025 VS 2032 Figure 27. Global 3D Printing Pharmaceuticals Sales Market Share by Application (2021-2032) Figure 28. Global 3D Printing Pharmaceuticals Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 29. Global 3D Printing Pharmaceuticals Revenue Market Share 2021 VS 2025 VS 2032 Figure 30. Global 3D Printing Pharmaceuticals Revenue Market Share by Application (2021-2032) Figure 31. North America 3D Printing Pharmaceuticals Sales and Growth Rate (2021-2032) & (k units) Figure 32. North America 3D Printing Pharmaceuticals Sales Market Share by Country (2021-2032) Figure 33. U.S. 3D Printing Pharmaceuticals Sales and Growth Rate (2021-2032) & (k units) Figure 34. Canada 3D Printing Pharmaceuticals Sales and Growth Rate (2021-2032) & (k units) Figure 35. Mexico 3D Printing Pharmaceuticals Sales and Growth Rate (2021-2032) & (k units) Figure 36. Europe 3D Printing Pharmaceuticals Sales and Growth Rate (2021-2032) & (k units) Figure 37. Europe 3D Printing Pharmaceuticals Sales Market Share by Country (2021-2032) Figure 38. Germany 3D Printing Pharmaceuticals Sales and Growth Rate (2021-2032) & (k units) Figure 39. France 3D Printing Pharmaceuticals Sales and Growth Rate (2021-2032) & (k units) Figure 40. U.K. 3D Printing Pharmaceuticals Sales and Growth Rate (2021-2032) & (k units) Figure 41. Italy 3D Printing Pharmaceuticals Sales and Growth Rate (2021-2032) & (k units) Figure 42. Netherlands 3D Printing Pharmaceuticals Sales and Growth Rate (2021-2032) & (k units) Figure 43. Asia Pacific 3D Printing Pharmaceuticals Sales and Growth Rate (2021-2032) & (k units) Figure 44. Asia Pacific 3D Printing Pharmaceuticals Sales Market Share by Country (2021-2032) Figure 45. China 3D Printing Pharmaceuticals Sales and Growth Rate (2021-2032) & (k units) Figure 46. Japan 3D Printing Pharmaceuticals Sales and Growth Rate (2021-2032) & (k units) Figure 47. South Korea 3D Printing Pharmaceuticals Sales and Growth Rate (2021-2032) & (k units) Figure 48. Southeast Asia 3D Printing Pharmaceuticals Sales and Growth Rate (2021-2032) & (k units) Figure 49. India 3D Printing Pharmaceuticals Sales and Growth Rate (2021-2032) & (k units) Figure 50. Australia 3D Printing Pharmaceuticals Sales and Growth Rate (2021-2032) & (k units) Figure 51. South America, Middle East and Africa 3D Printing Pharmaceuticals Sales and Growth Rate (2021-2032) & (k units) Figure 52. South America, Middle East and Africa 3D Printing Pharmaceuticals Sales Market Share by Country (2021-2032) Figure 53. Brazil 3D Printing Pharmaceuticals Sales and Growth Rate (2021-2032) & (k units) Figure 54. South Africa 3D Printing Pharmaceuticals Sales and Growth Rate (2021-2032) & (k units) Figure 55. Saudi Arabia 3D Printing Pharmaceuticals Sales and Growth Rate (2021-2032) & (k units) Figure 56. Turkey 3D Printing Pharmaceuticals Sales and Growth Rate (2021-2032) & (k units) Figure 57. Argentina 3D Printing Pharmaceuticals Sales and Growth Rate (2021-2032) & (k units) Figure 58. UAE 3D Printing Pharmaceuticals Sales and Growth Rate (2021-2032) & (k units) Figure 59. Egypt 3D Printing Pharmaceuticals Sales and Growth Rate (2021-2032) & (k units) Figure 60. Chile 3D Printing Pharmaceuticals Sales and Growth Rate (2021-2032) & (k units) Figure 61. Global 3D Printing Pharmaceuticals Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Global 3D Printing Pharmaceuticals Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 63. North America 3D Printing Pharmaceuticals Revenue (2021-2032) & (US$ Million) Figure 64. North America 3D Printing Pharmaceuticals Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Europe 3D Printing Pharmaceuticals Revenue (2021-2032) & (US$ Million) Figure 66. Europe 3D Printing Pharmaceuticals Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Asia-Pacific 3D Printing Pharmaceuticals Revenue (2021-2032) & (US$ Million) Figure 68. Asia-Pacific 3D Printing Pharmaceuticals Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 69. South America, Middle East and Africa 3D Printing Pharmaceuticals Revenue (2021-2032) & (US$ Million) Figure 70. South America, Middle East and Africa 3D Printing Pharmaceuticals Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 71. 3D Printing Pharmaceuticals Value Chain Figure 72. Manufacturing Cost Structure Figure 73. 3D Printing Pharmaceuticals Production Mode & Process Figure 74. Direct Comparison with Distribution Share Figure 75. Distributors Profiles Figure 76. Years Considered Figure 77. Research Process Figure 78. Key Executives Interviewed

Scope & coverage.

Types
  • DPE
  • SLS
  • MDD
  • FDM
  • MED
  • DOD
  • SLA
  • PB
  • SSE
Applications
  • Personalized Pharmacy
  • Nutrients
Companies covered
  • Merck KGaA
  • Merck
  • AstraZeneca
  • Triastek,Inc.
  • TNO
  • Therics
  • Multiply Labs
  • FabRx
  • DiHeSys
  • Aprecia

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global 3D Printing Pharmaceuticals Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global 3D Printing Pharmaceuticals Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global 3D Printing Pharmaceuticals Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global 3D Printing Pharmaceuticals Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global 3D Printing Pharmaceuticals Market Dynamics
  1. 2.1 3D Printing Pharmaceuticals Industry Trends
  2. 2.2 3D Printing Pharmaceuticals Industry Drivers
  3. 2.3 3D Printing Pharmaceuticals Industry Opportunities and Challenges
  4. 2.4 3D Printing Pharmaceuticals Industry Restraints
3 3D Printing Pharmaceuticals Market by Manufacturers
  1. 3.1 Global 3D Printing Pharmaceuticals Revenue by Manufacturers (2021-2026)
  2. 3.2 Global 3D Printing Pharmaceuticals Sales by Manufacturers (2021-2026)
  3. 3.3 Global 3D Printing Pharmaceuticals Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global 3D Printing Pharmaceuticals Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global 3D Printing Pharmaceuticals Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global 3D Printing Pharmaceuticals Manufacturers, Product Type & Application
  7. 3.7 Global 3D Printing Pharmaceuticals Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global 3D Printing Pharmaceuticals Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 3D Printing Pharmaceuticals Players Market Share by Revenue in 2025
  11. 3.8.3 2025 3D Printing Pharmaceuticals Tier 1, Tier 2, and Tier 3
4 3D Printing Pharmaceuticals Market by Type
  1. 4.1 3D Printing Pharmaceuticals Type Introduction
  2. 4.1.1 DPE
  3. 4.1.2 SLS
  4. 4.1.3 MDD
  5. 4.1.4 FDM
  6. 4.1.5 MED
  7. 4.1.6 DOD
  8. 4.1.7 SLA
  9. 4.1.8 PB
  10. 4.1.9 SSE
  11. 4.2 Global 3D Printing Pharmaceuticals Sales by Type
  12. 4.2.1 Global 3D Printing Pharmaceuticals Sales by Type (2021 VS 2025 VS 2032)
  13. 4.2.2 Global 3D Printing Pharmaceuticals Sales by Type (2021-2032)
  14. 4.2.3 Global 3D Printing Pharmaceuticals Sales Market Share by Type (2021-2032)
  15. 4.3 Global 3D Printing Pharmaceuticals Revenue by Type
  16. 4.3.1 Global 3D Printing Pharmaceuticals Revenue by Type (2021 VS 2025 VS 2032)
  17. 4.3.2 Global 3D Printing Pharmaceuticals Revenue by Type (2021-2032)
  18. 4.3.3 Global 3D Printing Pharmaceuticals Revenue Market Share by Type (2021-2032)
5 3D Printing Pharmaceuticals Market by Application
  1. 5.1 3D Printing Pharmaceuticals Application Introduction
  2. 5.1.1 Personalized Pharmacy
  3. 5.1.2 Nutrients
  4. 5.2 Global 3D Printing Pharmaceuticals Sales by Application
  5. 5.2.1 Global 3D Printing Pharmaceuticals Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global 3D Printing Pharmaceuticals Sales by Application (2021-2032)
  7. 5.2.3 Global 3D Printing Pharmaceuticals Sales Market Share by Application (2021-2032)
  8. 5.3 Global 3D Printing Pharmaceuticals Revenue by Application
  9. 5.3.1 Global 3D Printing Pharmaceuticals Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global 3D Printing Pharmaceuticals Revenue by Application (2021-2032)
  11. 5.3.3 Global 3D Printing Pharmaceuticals Revenue Market Share by Application (2021-2032)
6 Global 3D Printing Pharmaceuticals Sales by Region
  1. 6.1 Global 3D Printing Pharmaceuticals Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global 3D Printing Pharmaceuticals Sales by Region (2021-2032)
  3. 6.2.1 Global 3D Printing Pharmaceuticals Sales by Region (2021-2026)
  4. 6.2.2 Global 3D Printing Pharmaceuticals Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America 3D Printing Pharmaceuticals Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America 3D Printing Pharmaceuticals Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe 3D Printing Pharmaceuticals Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe 3D Printing Pharmaceuticals Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific 3D Printing Pharmaceuticals Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific 3D Printing Pharmaceuticals Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa 3D Printing Pharmaceuticals Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa 3D Printing Pharmaceuticals Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global 3D Printing Pharmaceuticals Revenue by Region
  1. 7.1 Global 3D Printing Pharmaceuticals Revenue by Region
  2. 7.1.1 Global 3D Printing Pharmaceuticals Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global 3D Printing Pharmaceuticals Revenue by Region (2021-2026)
  4. 7.1.3 Global 3D Printing Pharmaceuticals Revenue by Region (2027-2032)
  5. 7.1.4 Global 3D Printing Pharmaceuticals Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America 3D Printing Pharmaceuticals Revenue (2021-2032)
  8. 7.2.2 North America 3D Printing Pharmaceuticals Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe 3D Printing Pharmaceuticals Revenue (2021-2032)
  11. 7.3.2 Europe 3D Printing Pharmaceuticals Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific 3D Printing Pharmaceuticals Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific 3D Printing Pharmaceuticals Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa 3D Printing Pharmaceuticals Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa 3D Printing Pharmaceuticals Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Merck KGaA
  2. 8.1.1 Merck KGaA Company Information
  3. 8.1.2 Merck KGaA Business Overview
  4. 8.1.3 Merck KGaA 3D Printing Pharmaceuticals Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Merck KGaA 3D Printing Pharmaceuticals Product Portfolio
  6. 8.1.5 Merck KGaA Recent Developments
  7. 8.2 Merck
  8. 8.2.1 Merck Company Information
  9. 8.2.2 Merck Business Overview
  10. 8.2.3 Merck 3D Printing Pharmaceuticals Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Merck 3D Printing Pharmaceuticals Product Portfolio
  12. 8.2.5 Merck Recent Developments
  13. 8.3 AstraZeneca
  14. 8.3.1 AstraZeneca Company Information
  15. 8.3.2 AstraZeneca Business Overview
  16. 8.3.3 AstraZeneca 3D Printing Pharmaceuticals Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 AstraZeneca 3D Printing Pharmaceuticals Product Portfolio
  18. 8.3.5 AstraZeneca Recent Developments
  19. 8.4 Triastek,Inc.
  20. 8.4.1 Triastek,Inc. Company Information
  21. 8.4.2 Triastek,Inc. Business Overview
  22. 8.4.3 Triastek,Inc. 3D Printing Pharmaceuticals Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Triastek,Inc. 3D Printing Pharmaceuticals Product Portfolio
  24. 8.4.5 Triastek,Inc. Recent Developments
  25. 8.5 TNO
  26. 8.5.1 TNO Company Information
  27. 8.5.2 TNO Business Overview
  28. 8.5.3 TNO 3D Printing Pharmaceuticals Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 TNO 3D Printing Pharmaceuticals Product Portfolio
  30. 8.5.5 TNO Recent Developments
  31. 8.6 Therics
  32. 8.6.1 Therics Company Information
  33. 8.6.2 Therics Business Overview
  34. 8.6.3 Therics 3D Printing Pharmaceuticals Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Therics 3D Printing Pharmaceuticals Product Portfolio
  36. 8.6.5 Therics Recent Developments
  37. 8.7 Multiply Labs
  38. 8.7.1 Multiply Labs Company Information
  39. 8.7.2 Multiply Labs Business Overview
  40. 8.7.3 Multiply Labs 3D Printing Pharmaceuticals Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Multiply Labs 3D Printing Pharmaceuticals Product Portfolio
  42. 8.7.5 Multiply Labs Recent Developments
  43. 8.8 FabRx
  44. 8.8.1 FabRx Company Information
  45. 8.8.2 FabRx Business Overview
  46. 8.8.3 FabRx 3D Printing Pharmaceuticals Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 FabRx 3D Printing Pharmaceuticals Product Portfolio
  48. 8.8.5 FabRx Recent Developments
  49. 8.9 DiHeSys
  50. 8.9.1 DiHeSys Company Information
  51. 8.9.2 DiHeSys Business Overview
  52. 8.9.3 DiHeSys 3D Printing Pharmaceuticals Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 DiHeSys 3D Printing Pharmaceuticals Product Portfolio
  54. 8.9.5 DiHeSys Recent Developments
  55. 8.10 Aprecia
  56. 8.10.1 Aprecia Company Information
  57. 8.10.2 Aprecia Business Overview
  58. 8.10.3 Aprecia 3D Printing Pharmaceuticals Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Aprecia 3D Printing Pharmaceuticals Product Portfolio
  60. 8.10.5 Aprecia Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 3D Printing Pharmaceuticals Value Chain Analysis
  2. 9.1.1 3D Printing Pharmaceuticals Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 3D Printing Pharmaceuticals Production Mode & Process
  6. 9.2 3D Printing Pharmaceuticals Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 3D Printing Pharmaceuticals Distributors
  9. 9.2.3 3D Printing Pharmaceuticals Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst